Results - Announcements
Natco Pharma Ltd share price ticked higher by 0.02% to Rs 808.8 after the company's net profit soared by 41.90% to Rs 173.4 crore, while revenue from operations increased sharply by 31.57% to Rs 967.3 crore in Q2FY27 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.83 lakh crore, rising 6.59%. It has improved by 2.89% over last one week and ticked higher by 6.37% in last one month while the market capitalization of Natco Pharma Ltd has marginally improved by 0.20% and 1.84% in the same period respectively.
Profit before tax (PBT) of Natco Pharma Ltd stood at Rs 243.2 crore in Q2 FY27, plunging by 60.37% year-on-year, and jumping 31.03% quarter-on-quarter. EBITDA came in at Rs 206 crore, crashing by 57.05% YoY and rallying 61.67% sequentially.
Total expenses jumped by 27.32% to Rs 758.6 crore in Q2FY27 over Q2FY26. During the quarter, cost of materials consumed stood at Rs 171.7 crore, growing marginally by 8.81% YoY, while employee benefits expense was at Rs 203.6 crore, soaring 13.55% YoY.
For FY26, revenue from operations declined slightly by 7.93% to Rs 4078.3 crore, while net profit tanked by 27.16% to Rs 1371.9 crore, compared to previous FY. EBITDA witnessed a strong improvement of 181190% to Rs 1138.9 crore, and PBT plunged by 34.94% to Rs 1490.8 crore compared to previous FY.
The company's consolidated net cash flow from operating activities stood at Rs 1768.3 crore in FY26, as against Rs 1696.8 crore in FY25.
Natco Pharma Ltd declined by 0.95% in last one year, outperforming the benchmark BSE Sensex which has slipped by 3.03% during the same period.